Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Avai Bio (AVAI) Assets Average (2018 - 2023)

Avai Bio's Assets Average history spans 5 years, with the latest figure at $278153.5 for Q4 2023.

  • For Q4 2023, Assets Average fell 10.78% year-over-year to $278153.5; the TTM value through Dec 2023 reached $278153.5, down 10.78%, while the annual FY2020 figure was $185179.5, N/A changed from the prior year.
  • Assets Average for Q4 2023 was $278153.5 at Avai Bio, up from $269740.0 in the prior quarter.
  • Across five years, Assets Average topped out at $725250.5 in Q4 2020 and bottomed at -$54888.5 in Q3 2019.
  • The 4-year median for Assets Average is $278153.5 (2023), against an average of $288716.0.
  • The largest annual shift saw Assets Average tumbled 266.29% in 2019 before it surged 17730.98% in 2020.
  • A 4-year view of Assets Average shows it stood at $21884.0 in 2019, then soared by 3214.07% to $725250.5 in 2020, then tumbled by 57.01% to $311768.0 in 2022, then dropped by 10.78% to $278153.5 in 2023.
  • Per Business Quant, the three most recent readings for AVAI's Assets Average are $278153.5 (Q4 2023), $269740.0 (Q3 2023), and $257939.5 (Q2 2023).